Drug Addiction

Congress does not pass one law on addiction. It votes on drug schedules, sanctions, prison sentences, grant programs, and what a doctor may prescribe, and where a member stands is the sum of those smaller answers. The measures divide along a familiar line: one set attacks the drug supply and raises penalties, another expands access to treatment, and a few bills draw real support from both.

One set would attack the drug supply and raise the penalties. The bill furthest along is already law: it permanently places every chemical cousin of fentanyl into Schedule I, the strictest federal control category, so making or selling any of them carries fentanyl's own trafficking penalties. A second, which has passed the House, would let the government impose sanctions on the Chinese suppliers of the raw chemicals used to make fentanyl. A third, still in committee, would lower the amount of fentanyl that triggers a mandatory-minimum prison sentence, so far smaller quantities carry the automatic penalties that today apply only to large ones. Despite its name, the "Fairness in Fentanyl Sentencing Act," it makes those sentences harsher, not lighter.

Between those two sides is the one bill that became law with support from both parties. It reauthorizes through 2030 the federal government's main set of grant programs for preventing and treating substance use disorders, the clinical term for addiction: money for youth prevention, recovery housing, peer support, overdose-reversal drugs, and loan repayment for treatment providers. It passed the House 366 to 57 and cleared the Senate without objection.

A third set would expand access to treatment. One would permanently let clinicians prescribe medications for opioid use disorder, such as buprenorphine, over telehealth rather than only in person. Another would let ordinary pharmacies dispense methadone for addiction, which today can be filled only at a limited number of specially licensed clinics. A third would fund one-stop state treatment sites through a Medicaid pilot. None of the three has reached a vote.

That changes how to read the numbers below, which are ordered by how far each bill got rather than by where it falls on this spectrum. On this issue the strongest signal is one-sided, and the reason is procedural, not editorial. The enforcement bills reached the floor. One became law with recorded votes in both chambers, and another passed the House, so those members are on the record by name. The bills that would expand treatment all sit in committee, where the only measure of support is who signed on as a cosponsor. So the two kinds of evidence do not carry the same weight: a recorded vote places every member, while cosponsorship places only those who put their name down. The treatment side is measured by cosponsorship because those bills never got a vote, not because members declined to take a position.

The words here are chosen to describe what each bill does, not to take a side. This page says "a person with a substance use disorder," not "addict"; "substance use," not "drug abuse"; "medications for opioid use disorder," and it names the mechanism each bill uses rather than the slogans that attach to this debate. Where a bill's own name would mislead, the description says plainly what the bill actually does.

None of these bills is endorsed here. They are chosen because together they map the real range of what Congress is weighing, from harsher trafficking penalties to expanded treatment, and because each vote and cosponsorship is a documented fact you can check yourself in the record linked below.